메뉴 건너뛰기




Volumn 11, Issue 3, 2016, Pages 2169-2175

Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma

Author keywords

Calreticulin; Dendritic cell; Doxorubicin; Heat shock protein 70; High mobility group box 1; Immunogenic cell death; Osteosarcoma

Indexed keywords

CALRETICULIN; DOXORUBICIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 12;

EID: 84958064362     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4175     Document Type: Article
Times cited : (58)

References (24)
  • 1
    • 33747358308 scopus 로고    scopus 로고
    • Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project
    • Stiller CA, Bielack SS, Jundt G and Steliarova–Foucher E: Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42: 2124–2135, 2006.
    • (2006) Eur J Cancer , vol.42 , pp. 2124-2135
    • Stiller, C.A.1    Bielack, S.S.2    Jundt, G.3
  • 2
    • 0036467661 scopus 로고    scopus 로고
    • Prognostic factors in high–grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
    • Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, et al: Prognostic factors in high–grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776–790, 2002.
    • (2002) J Clin Oncol , vol.20 , pp. 776-790
    • Bielack, S.S.1    Kempf-Bielack, B.2    Delling, G.3    Exner, G.U.4    Flege, S.5    Helmke, K.6    Kotz, R.7    Salzer-Kuntschik, M.8    Werner, M.9    Winkelmann, W.10
  • 3
    • 0035694563 scopus 로고    scopus 로고
    • The different level of immunological recovery after chemotherapy in leukemia and lymphoma patients
    • Milosević DB: The different level of immunological recovery after chemotherapy in leukemia and lymphoma patients. J Exp Clin Cancer Res 20: 517–522, 2001.
    • (2001) J Exp Clin Cancer Res , vol.20 , pp. 517-522
    • Milosević, D.B.1
  • 5
    • 41549145181 scopus 로고    scopus 로고
    • Immunogenicity of anthracyclines: Moving towards more personalized medicine
    • Apetoh L, Mignot G, Panaretakis T, Kroemer G and Zitvogel L: Immunogenicity of anthracyclines: Moving towards more personalized medicine. Trends Mol Med 14: 141–151, 2008.
    • (2008) Trends Mol Med , vol.14 , pp. 141-151
    • Apetoh, L.1    Mignot, G.2    Panaretakis, T.3    Kroemer, G.4    Zitvogel, L.5
  • 9
    • 37049031915 scopus 로고    scopus 로고
    • Factors influencing the generation of murine dendritic cells from bone marrow: The special role of fetal calf serum
    • Lutz MB and Rössner S: Factors influencing the generation of murine dendritic cells from bone marrow: The special role of fetal calf serum. Immunobiology 212: 855–862, 2007.
    • (2007) Immunobiology , vol.212 , pp. 855-862
    • Lutz, M.B.1    Rössner, S.2
  • 10
    • 77953288334 scopus 로고    scopus 로고
    • Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma
    • Kawano M, Nishida H, Nakamoto Y, Tsumura H and Tsuchiya H: Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma. Clin Orthop Relat Res 468: 1373–1383, 2010.
    • (2010) Clin Orthop Relat Res , vol.468 , pp. 1373-1383
    • Kawano, M.1    Nishida, H.2    Nakamoto, Y.3    Tsumura, H.4    Tsuchiya, H.5
  • 11
    • 84866462218 scopus 로고    scopus 로고
    • Anti–TGF–β antibody combined with dendritic cells produce antitumor effects in osteosarcoma
    • Kawano M, Itonaga I, Iwasaki T, Tsuchiya H and Tsumura H: Anti–TGF–β antibody combined with dendritic cells produce antitumor effects in osteosarcoma. Clin Orthop Relat Res 470: 2288–2294, 2012.
    • (2012) Clin Orthop Relat Res , vol.470 , pp. 2288-2294
    • Kawano, M.1    Itonaga, I.2    Iwasaki, T.3    Tsuchiya, H.4    Tsumura, H.5
  • 12
    • 84872787611 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by combining anti–cytotoxic T lymphocyte antigen–4 antibodies and cryotreated tumor lysate–pulsed dendritic cells in murine osteosarcoma
    • Kawano M, Itonaga I, Iwasaki T and Tsumura H: Enhancement of antitumor immunity by combining anti–cytotoxic T lymphocyte antigen–4 antibodies and cryotreated tumor lysate–pulsed dendritic cells in murine osteosarcoma. Oncol Rep 29: 1001–1006, 2013.
    • (2013) Oncol Rep , vol.29 , pp. 1001-1006
    • Kawano, M.1    Itonaga, I.2    Iwasaki, T.3    Tsumura, H.4
  • 13
    • 79952390627 scopus 로고    scopus 로고
    • Immune parameters affecting the efficacy of chemotherapeutic regimens
    • Zitvogel L, Kepp O and Kroemer G: Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol 8: 151–160, 2011.
    • (2011) Nat Rev Clin Oncol , vol.8 , pp. 151-160
    • Zitvogel, L.1    Kepp, O.2    Kroemer, G.3
  • 15
    • 77953701142 scopus 로고    scopus 로고
    • Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway
    • Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N and Kroemer G: Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway. Clin Cancer Res 16: 3100–3104, 2010.
    • (2010) Clin Cancer Res , vol.16 , pp. 3100-3104
    • Zitvogel, L.1    Kepp, O.2    Senovilla, L.3    Menger, L.4    Chaput, N.5    Kroemer, G.6
  • 17
    • 84902480051 scopus 로고    scopus 로고
    • Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
    • Michaud M, Sukkurwala AQ, Di Sano F, Zitvogel L, Kepp O and Kroemer G: Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress. Oncoimmunology 3: e28276, 2014.
    • (2014) Oncoimmunology , vol.3
    • Michaud, M.1    Sukkurwala, A.Q.2    Di Sano, F.3    Zitvogel, L.4    Kepp, O.5    Kroemer, G.6
  • 18
    • 48549095188 scopus 로고    scopus 로고
    • Nucleic acid sensing toll–like receptors in dendritic cells
    • Hoshino K and Kaisho T: Nucleic acid sensing toll–like receptors in dendritic cells. Curr Opin Immunol 20: 408–413, 2008.
    • (2008) Curr Opin Immunol , vol.20 , pp. 408-413
    • Hoshino, K.1    Kaisho, T.2
  • 19
    • 0032816123 scopus 로고    scopus 로고
    • Proinflammatory cytokines (Tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein–1 by pituicytes
    • Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A and Tracey KJ: Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein–1 by pituicytes. Surgery 126: 389–392, 1999.
    • (1999) Surgery , vol.126 , pp. 389-392
    • Wang, H.1    Vishnubhakat, J.M.2    Bloom, O.3    Zhang, M.4    Ombrellino, M.5    Sama, A.6    Tracey, K.J.7
  • 20
    • 0037062934 scopus 로고    scopus 로고
    • Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
    • Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191–195, 2002.
    • (2002) Nature , vol.418 , pp. 191-195
    • Scaffidi, P.1    Misteli, T.2    Bianchi, M.E.3
  • 21
    • 1542380035 scopus 로고    scopus 로고
    • Involvement of toll–like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
    • Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A and Abraham E: Involvement of toll–like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370–7377, 2004.
    • (2004) J Biol Chem , vol.279 , pp. 7370-7377
    • Park, J.S.1    Svetkauskaite, D.2    He, Q.3    Kim, J.Y.4    Strassheim, D.5    Ishizaka, A.6    Abraham, E.7
  • 24
    • 33751209215 scopus 로고    scopus 로고
    • Combined chemoimmunotherapy of solid tumours: Improving vaccines?
    • Nowak AK, Lake RA and Robinson BW: Combined chemoimmunotherapy of solid tumours: Improving vaccines? Adv Drug Deliv Rev 58: 975–990, 2006.
    • (2006) Adv Drug Deliv Rev , vol.58 , pp. 975-990
    • Nowak, A.K.1    Lake, R.A.2    Robinson, B.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.